The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Abstract

We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the effects of magnesium (Mg) supplementation on the lipid profile in type 2 diabetes (T2DM) patients. Web of Science, Scopus, PubMed, and Embase databases were searched to infinity until 30 January 2020. Weighted mean differences (WMD) were pooled using a random-effects model. Heterogeneity, sensitivity analysis, and publication bias were reported using standard methods. The pooled analysis of 12 randomized controlled trials indicated that Mg administration led to significant reduction of serum low-density lipoprotein (LDL) levels (p = 0.006). However, our results revealed that Mg supplementation did not have any effect on triglycerides (TG), total cholesterol (TC), and high-density lipoprotein (HDL) serum concentrations among T2DM patients in comparison with the control group. Subgroup analysis based on duration of study suggested that more than 12 weeks of Mg supplementation significantly decreased the serum TC levels (p = 0.002). Subgroup analysis comparing the dose of intervention indicated that Mg supplementation less than 300 mg significantly decreased the serum LDL concentrations (p < 0.001), while more than 300 mg of Mg supplementation significantly increased the serum HDL levels (p = 0.026). In a subgroup analysis comparing the type of intervention, it displayed that inorganic Mg supplementation decreased the LDL (p < 0.001) and TC (p = 0.003) levels, while organic Mg supplementation showed no difference. Mg supplementation has a beneficial effect on lowering LDL level in T2DM patients. However, we have to note that any research performed so far is not sufficient for making robust guidelines to use Mg supplementation in clinical practice.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. 1.

    Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(1):4–14

    CAS  Article  Google Scholar 

  2. 2.

    Beigrezaei S, Ghiasvand R, Feizi A, Iraj B (2019) Relationship between dietary patterns and incidence of type 2 diabetes. Int J Prev Med 10(122): 2

  3. 3.

    Shi Y, Hu FB (2014) The global implications of diabetes and cancer. Lancet (London, England) 383(9933):1947

    Article  Google Scholar 

  4. 4.

    Namazi N, Tarighat A, Bahrami A (2012) The effect of hydro alcoholic nettle (Urtica dioica) extract on oxidative stress in patients with type 2 diabetes: a randomized double-blind clinical trial. Pak J Biol Sci 15(2):98–102

    CAS  Article  Google Scholar 

  5. 5.

    Hosseini SM, Amini M, Roosta S, Beigrezaei S (2016) Trends of serum creatinine among patients with type 2 diabetes in Isfahan endocrine and metabolism research center; a longitudinal study. J Prev Epidemiol 2(1): e01

  6. 6.

    Motedayen M, Sarokhani D, Meysami A, Jouybari L, Sanagoo A, Hasanpour DA (2018) The prevalence of hypertension in diabetic patients in Iran; a systematic review and meta-analysis. J Nephropathol 7(3):137–144

  7. 7.

    Zhou Y, Wang C, Shi K, Yin X (2018) Relationship between dyslipidemia and diabetic retinopathy: a systematic review and meta-analysis. Medicine 97(36):e12283

    Article  Google Scholar 

  8. 8.

    Mohammadi H, Hadi A, Arab A, Moradi S, Rouhani MH (2019) Effects of silymarin supplementation on blood lipids: a systematic review and meta-analysis of clinical trials. Phytother Res 33(4):871–880

    CAS  Article  Google Scholar 

  9. 9.

    Ghaedi E, Moradi S, Aslani Z, Kord-Varkaneh H, Miraghajani M, Mohammadi H (2019) Effects of grape products on blood lipids: a systematic review and dose–response meta-analysis of randomized controlled trials. Food Funct 10(10):6399–6416

    CAS  Article  Google Scholar 

  10. 10.

    Behradmanesh S, Nasri P (2012) Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients. J Renal Inj Prev 1(1):23–26

    PubMed  PubMed Central  Google Scholar 

  11. 11.

    Nasri H, Shirzad H, Baradaran A, Rafieian-Kopaei M (2015) Antioxidant plants and diabetes mellitus. J Res Med Sci 20(5):491

  12. 12.

    Jonnalagadda VG, Shravan Kumar U, Afsar S (2018) Effect of metformin or Chinese herbal formula in patients with type 2 diabetes mellitus and hyperlipidemia: a reassessment. mBio 24;9(4):e01173–18

  13. 13.

    Barbagallo M, Dominguez LJ (2015) Magnesium and type 2 diabetes. World J Diabetes 6(10):1152–1157

    Article  Google Scholar 

  14. 14.

    Niknazar F, Aberumand M, Rostami R, Seyed TM (2013) Evaluation of serum magnesium in type II diabetic patients. Med Lab J 7(1):12–16

    Google Scholar 

  15. 15.

    Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo’ A, Paolisso G (2003) Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Asp Med 24(1–3):39–52

    CAS  Article  Google Scholar 

  16. 16.

    Corica F, Allegra A, Di AB, Giacobbe M, Romano G, Cucinotta D et al (1994) Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 7(1):43–47

    CAS  PubMed  Google Scholar 

  17. 17.

    Rashvand S, Mobasseri M, Tarighat-Esfanjani A (2019) Effects of choline and magnesium concurrent supplementation on coagulation and lipid profile in patients with type 2 diabetes mellitus: a pilot clinical trial. Biol Trace Elem Res194(2):328–335

  18. 18.

    Wang J (1987) Determination of intraerythrocytic Na+, K+, Ca++, Mg++ and cell-membrane Na+-K+-ATPase activities: its diagnostic value in digoxin poisoning. Zhonghua Yi Xue Za Zhi 67(7):366

    CAS  PubMed  Google Scholar 

  19. 19.

    McNair P, Christiansen C, Madsbad S, Lauritzen E, Faber O, Binder C, Transbol I (1978) Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes. 27(11):1075–1077

    CAS  Article  Google Scholar 

  20. 20.

    McNair P, Christensen MS, Christiansen C, Madsbad S, Transbøl I (1982) Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Investig 12(1):81–85

    CAS  Article  Google Scholar 

  21. 21.

    Paolisso G, Ravussin E (1995) Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. J Clin Endocrinol Metab 80(4):1382–1385

  22. 22.

    Nasri H (2014) Consequences of hypomagnesemia in type 2 diabetes mellitus patients. J Renal Inj Prev 3(4):99–100

  23. 23.

    Madihi Y, Marikhi A, Nasri H (2013) Prevention of hypomagnesemia in diabetes patients. Int J Prev Med 1(1):982–983

    Google Scholar 

  24. 24.

    Nasri H, Baradaran H-R (2008) Lipids in association with serum magnesium in diabetes mellitus patients. Bratisl Lek Listy 109(7):302–306

  25. 25.

    Solati M, Ouspid E, Hosseini S, Soltani N, Keshavarz M, Dehghani M (2014) Oral magnesium supplementation in type II diabetic patients. Med J Islam Repub Iran 28:67

    PubMed  PubMed Central  Google Scholar 

  26. 26.

    Sadeghian M, Azadbakht L, Khalili N, Mortazavi M, Esmaillzadeh A (2020) Oral magnesium supplementation improved lipid profile but increased insulin resistance in patients with diabetic nephropathy: a double-blind randomized controlled clinical trial. Biol Trace Elem Res 193(1):23–35

    CAS  Article  Google Scholar 

  27. 27.

    De Valk H, Verkaaik R, Van Rijn H, Geerdink R, Struyvenberg A (1998) Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabet Med 15(6):503–507

    Article  Google Scholar 

  28. 28.

    Mansouri A, Norouzi S, Sharifi A, YektaKooshali MH, Azami M (2017) The relationship of maternal subclinical hypothyroidism during pregnancy and preterm birth: a systematic review and meta-analysis of cohort studies. J Clin Endocrinol Metab 19(40):69–78

  29. 29.

    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097

    Article  Google Scholar 

  30. 30.

    Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 343:d5928

    Article  Google Scholar 

  31. 31.

    Mirenayat MS, Moradi S, Mohammadi H, Rouhani MH (2018) Effect of L-citrulline supplementation on blood pressure: a systematic review and meta-analysis of clinical trials. Curr Hypertens Rep 20(11):98

    Article  Google Scholar 

  32. 32.

    Moradi S, Ziaei R, Foshati S, Mohammadi H, Nachvak SM, Rouhani MH. Effects of Spirulina supplementation on obesity: A systematic review and metaanalysis of randomized clinical trials. Complementary therapies in medicine. 2019;47:102211

  33. 33.

    DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28(2):105–114

  34. 34.

    Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14(1):135

    Article  Google Scholar 

  35. 35.

    Eibl NL, Kopp H-P, Nowak HR, Schnack CJ, Hopmeier PG, Schernthaner G (1995) Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care 18(2):188–192

    CAS  Article  Google Scholar 

  36. 36.

    Rodríguez-Morán M, Guerrero-Romero F (2003) Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 26(4):1147–1152

    Article  Google Scholar 

  37. 37.

    Barragán-Rodríguez L, Rodríguez-Morán M, Guerrero-Romero F (2008) Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res 21(4):218–223

    PubMed  Google Scholar 

  38. 38.

    Guerrero-Romero F, Rodriguez-Moran M (2009) The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 23(4):245–251

    CAS  Article  Google Scholar 

  39. 39.

    Navarrete-Cortes A, Ble-Castillo JL, Guerrero-Romero F, Cordova-Uscanga R, Juárez-Rojop IE, Aguilar-Mariscal H, et al. No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia. Magnesium research. 2014;27(2):48–56

  40. 40.

    Razzaghi R, Pidar F, Momen-Heravi M, Bahmani F, Akbari H, Asemi Z (2018) Magnesium supplementation and the effects on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res 181(2):207–215

    CAS  Article  Google Scholar 

  41. 41.

    Sadeghian M, Azadbakht L, Khalili N, Mortazavi M, Esmaillzadeh A (2019) Oral magnesium supplementation improved lipid profile but increased insulin resistance in patients with diabetic nephropathy: a double-blind randomized controlled clinical trial. Biol Trace Elem Res 193(1):23–35

  42. 42.

    Talari HR, Zakizade M, Soleimani A, Bahmani F, Ghaderi A, Mirhosseini N, Eslahi M, Babadi M, Mansournia MA, Asemi Z (2019) Effects of magnesium supplementation on carotid intima-media thickness and metabolic profiles in diabetic haemodialysis patients: a randomised, double-blind, placebo-controlled trial. Br J Nutr 121(7):809–817

    CAS  Article  Google Scholar 

  43. 43.

    Nasri H, Behradmanesh S, Ahmadi A, Baradaran A, Nasri P, Rafieian-Kopaei M (2014) Association of serum lipids with level of blood pressure in type 2 diabetic patients. J Renal Inj Prev 3(2):43

  44. 44.

    Gatmiri SM, Khadem E, Fakhrian T, Kamalinejad M, Hosseini H, Ghorat F, Alamdari A, Naderi N (2019) The effect of artichoke leaf extract supplementation on lipid profile of chronic kidney disease patients; a double-blind, randomized clinical trial. J Renal Inj Prev 8(3):225–229

    CAS  Article  Google Scholar 

  45. 45.

    Rashvand S, Mobasseri M, Tarighat-Esfanjani A (2019) Effects of choline and magnesium concurrent supplementation on coagulation and lipid profile in patients with type 2 diabetes mellitus: a pilot clinical trial. Biol Trace Elem Res 194(2):328–335

  46. 46.

    Pourjam R, Estebsari F, ZRK K, Estebsri K, Mostafaei D (2019) An analytical study of the factors affecting the health promoting lifestyle; comparison of type II diabetic patients with healthy people. J Renal Inj Prev 8(3): 247–252

  47. 47.

    Kaveh P, Tehrani AM, Mardani S (2020) Association of serum magnesium level with resistant hyperlipidemia in diabetic and hypertensive patients. J Nephropharmacol 9(1): e07

  48. 48.

    Verma H, Garg R (2017) Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta analysis.J Hum Nutr Diet 30(5):621–633

  49. 49.

    Simental-Mendía LE, Simental-Mendía M, Sahebkar A, Rodríguez-Morán M, Guerrero-Romero F (2017) Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 73(5):525–536

    Article  Google Scholar 

  50. 50.

    Coudray C, Rambeau M, Feillet-Coudray C, Gueux E, Tressol J, Mazur A, Rayssiguier Y (2005) Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnes Res 18(4):215–223

    CAS  PubMed  Google Scholar 

  51. 51.

    Guerrero-Romero F, Jaquez-Chairez FO, Rodriguez-Moran M (2016) Magnesium in metabolic syndrome: a review based on randomized, double-blind clinical trials. Magnes Res 29(4):146–153

    CAS  Article  Google Scholar 

  52. 52.

    Marques B, Klein M, da Cunha MR, de Souza Mattos S, de Paula Nogueira L, de Paula T, et al. Effects of Oral magnesium supplementation on vascular function: a systematic review and meta-analysis of randomized controlled trials. High Blood Press Cardiovasc Prev 27(1):19–28

  53. 53.

    Navarro-González JF, Mora-Fernández C, García-Pérez J (eds) (2009) Reviews: clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Seminars in dialysis. Semin Dial 22(1):37–44

  54. 54.

    Noale M, Limongi F, Maggi S (2020) Epidemiology of cardiovascular diseases in the elderly. Adv Exp Med Biol 1216:29–38

    Article  Google Scholar 

  55. 55.

    Taghizadeh E, Esfehani RJ, Sahebkar A. Familial combined hyperlipidemia: an overview of the underlying molecular mechanisms and therapeutic strategies IUBMB Life 71(9):1221–1229

  56. 56.

    van Reedt Dortland AK, Vreeburg SA, Giltay EJ, Licht CM, Vogelzangs N, van Veen T et al (2013) The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology. 38(2):209–218

    Article  Google Scholar 

  57. 57.

    Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism Rev Endocr Metab Disord 20(4):461–472

  58. 58.

    Rosanoff A, Seelig MS (2004) Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr 23(5):501S–505S

    CAS  Article  Google Scholar 

  59. 59.

    Simental-Mendia LE, Simental-Mendia M, Sahebkar A, Rodriguez-Moran M, Guerrero-Romero F (2017) Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 73(5):525–536

    CAS  Article  Google Scholar 

  60. 60.

    Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A (2010) Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif 29(3):280–292

    CAS  Article  Google Scholar 

  61. 61.

    Spiegel DM (2011) Magnesium in chronic kidney disease: unanswered questions. Blood Purif 31(1–3):172–176

    CAS  Article  Google Scholar 

  62. 62.

    Sultan S, Jahangir A, Gussak IB, Kostis JB, JamilTajik A, Jahangir A (2018) CHAPTER 29. Interactions between supplements and medications. Iatrogenicity: causes and consequences of iatrogenesis in cardiovascular medicine:370–389

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Sajjad Moradi or Maryam Miraghajani.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(DOC 32 kb)

ESM 2

(DOC 27 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Asbaghi, O., Moradi, S., Nezamoleslami, S. et al. The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Biol Trace Elem Res 199, 861–873 (2021). https://doi.org/10.1007/s12011-020-02209-5

Download citation

Keywords

  • Magnesium supplementation
  • Lipid profile
  • Obesity
  • Type 2 diabetes
  • Meta-analysis